MedTrace Logo

Clinical Trial of Crocus Kozanis Administration in Obese Children and Adolescents

NCT05572749 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2024-02-08

No results posted yet for this study

Summary

The study aims to investigate possible effects of per os Crocus Kozanis administration in children and adolescents with obesity

Conditions

Interventions

DIETARY_SUPPLEMENT

Crocus Kozanis

In this study, intervention will be the administration of Crocus Kozanis dietary supplement. Crocus Kozanis is a herb which is cultivated in Kozani, Greece.

DIETARY_SUPPLEMENT

Placebo of Crocus Kozanis

Placebo of Crocus Kozanis

DRUG

Metformin

Metformin will be administered in a dosage of 1000mg per day. Metformin is a formally approved therapy for children with diabetes in Europe.

Sponsors & Collaborators

  • Aristotle University Of Thessaloniki

    lead OTHER

Principal Investigators

  • Assimina Galli-Tsinopoulou, Professor · Aristotle University Of Thessaloniki

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
10 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-01
Primary Completion
2023-09-30
Completion
2023-09-30

Countries

  • Greece

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05572749 on ClinicalTrials.gov